6.
Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D
. COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020; 201(10):1299-1300.
PMC: 7233352.
DOI: 10.1164/rccm.202003-0817LE.
View
7.
Stahl K, Brasen J, Hoeper M, David S
. Direct evidence of SARS-CoV-2 in gut endothelium. Intensive Care Med. 2020; 46(11):2081-2082.
PMC: 7483488.
DOI: 10.1007/s00134-020-06237-6.
View
8.
Hui K, Cheung M, Perera R, Ng K, Bui C, Ho J
. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020; 8(7):687-695.
PMC: 7252187.
DOI: 10.1016/S2213-2600(20)30193-4.
View
9.
Rezaei A, Neshat S, Heshmat-Ghahdarijani K
. Alterations of Lipid Profile in COVID-19: A Narrative Review. Curr Probl Cardiol. 2021; 47(3):100907.
PMC: 8161768.
DOI: 10.1016/j.cpcardiol.2021.100907.
View
10.
Ma Z, Yang K, Huang Y, Lui K
. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol. 2021; 164:69-82.
PMC: 8610843.
DOI: 10.1016/j.yjmcc.2021.11.010.
View
11.
Subramaniam S, Kenney D, Jayaraman A, OConnell A, Walachowski S, Montanaro P
. Aging is associated with an insufficient early inflammatory response of lung endothelial cells in SARS-CoV-2 infection. Front Immunol. 2024; 15:1397990.
PMC: 11190167.
DOI: 10.3389/fimmu.2024.1397990.
View
12.
Puelles V, Lutgehetmann M, Lindenmeyer M, Sperhake J, Wong M, Allweiss L
. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 2020; 383(6):590-592.
PMC: 7240771.
DOI: 10.1056/NEJMc2011400.
View
13.
Carossino M, Kenney D, OConnell A, Montanaro P, Tseng A, Gertje H
. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression. Viruses. 2022; 14(3).
PMC: 8955233.
DOI: 10.3390/v14030535.
View
14.
Zaim S, Chong J, Sankaranarayanan V, Harky A
. COVID-19 and Multiorgan Response. Curr Probl Cardiol. 2020; 45(8):100618.
PMC: 7187881.
DOI: 10.1016/j.cpcardiol.2020.100618.
View
15.
Akima S, McLintock C, Hunt B
. RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020; 18(8):2057-2058.
PMC: 9770917.
DOI: 10.1111/jth.14853.
View
16.
Bode M, Mackman N
. Regulation of tissue factor gene expression in monocytes and endothelial cells: Thromboxane A2 as a new player. Vascul Pharmacol. 2014; 62(2):57-62.
PMC: 4116464.
DOI: 10.1016/j.vph.2014.05.005.
View
17.
Subramaniam S, Jurk K, Hobohm L, Jackel S, Saffarzadeh M, Schwierczek K
. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood. 2017; 129(16):2291-2302.
PMC: 5399485.
DOI: 10.1182/blood-2016-11-749879.
View
18.
Szotowski B, Antoniak S, Poller W, Schultheiss H, Rauch U
. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res. 2005; 96(12):1233-9.
DOI: 10.1161/01.RES.0000171805.24799.fa.
View
19.
Conde J, Schutt W, Gorbunova E, Mackow E
. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses. mBio. 2020; 11(6).
PMC: 7751258.
DOI: 10.1128/mBio.03185-20.
View
20.
Chen D, Chin C, Kenney D, Tavares A, Khan N, Conway H
. Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation. Nature. 2023; 615(7950):143-150.
DOI: 10.1038/s41586-023-05697-2.
View